The Pharmaceutical Automation and Digitalisation Congress (AutomaPlus)  2026 is a closed-door event that focuses on the end-to-end digital transformation – from R&D and laboratory automation to manufacturing, packaging, supply chain, compliance and commercial operations. Hosted in Zurich on 16-17 November 2026, the Congress addresses the real constraints shaping digital transformation in pharma – from data integrity and validation to scalability and return on investment.

AutomaPlus 2026 features perspectives from GSK, Takeda, Novartis, Roche, Johnson & Johnson, SCARLETRED Holding GmbH, WHO and others, reflecting a cross-section of pharmaceutical manufacturing, research, public health and technology expertise. With its focus on applied use cases, AutomaPlus 2026  demonstrates the practical implementation of automation and digitalisation across regulated pharmaceutical environments today.

Find out where pharma automation stands today: https://sh.bgs.group/4vt